Glioma is a peer-reviewed english-language open-access journal published by Wolters Kluwer Medknow Publications in India, operating under an open-access model since 2018. The journal covers Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens.
Authors publish in Glioma without paying any article processing charge (APC) — making it a fully diamond/platinum open-access venue, supported entirely by its publisher or sponsor. Articles are released under the CC BY-NC-SA license (see other journals using this license).
Keywords
biotherapy, chemotherapy, glioma, central nervous system tumours, radiotherapy
At a glance
- Publisher
- Wolters Kluwer Medknow Publications
- Country
- India
- Primary language
- English
- License
- CC BY-NC-SA
- Peer review
- Double anonymous peer review
- OA since
- 2018
ISSN
- 2589-6113
- electronic
- 2589-6121
Frequently asked questions
Is Glioma peer-reviewed?
Yes — Glioma operates a Double anonymous peer review review process.
Does Glioma charge an article processing charge (APC)?
No. Glioma does not charge any APC. Publication is free for accepted authors.
What subjects does Glioma publish?
Glioma publishes research in Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens.
What languages does Glioma accept?
Glioma accepts manuscripts in English.
What is the ISSN of Glioma?
ISSN:
2589-6113 (print) · 2589-6121 (electronic).How do I submit a manuscript to Glioma?
Submit through the journal's official portal: visit submission page →